Chester S. Zygmont III - 10 Jan 2022 Form 3 Insider Report for REVELATION BIOSCIENCES, INC. (REVB)

Role
Chief Financial Officer
Signature
/s/ J.P. Galda, as attorney-in-fact for Chester S Zygmont, III
Issuer symbol
REVB
Transactions as of
10 Jan 2022
Net transactions value
$0
Form type
3
Filing time
20 Jan 2022, 17:07:08 UTC
Next filing
28 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding REVB Common Stock 463,285 10 Jan 2022 By Trust F1
holding REVB Common Stock 218,017 10 Jan 2022 By LLC F2
holding REVB Common Stock 2,144 10 Jan 2022 By Spouse F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding REVB Restricted Stock Unit 10 Jan 2022 Common Stock 6,853 Direct F4, F5, F6
holding REVB Restricted Stock Unit 10 Jan 2022 Common Stock 15,588 Direct F5, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are held by The Zygmont Family Trust Dated October 25, 2016, with respect to which Chester S Zygmont III is a trustee.
F2 Shares are held by Czeslaw Capital Fund, LLC. Chester S Zygmont III is the sole manager of Czeslaw Capital Fund, LLC.
F3 The Reporting Person disclaims beneficial ownership of shares held by the Reporting Person's spouse directly.
F4 These RSUs vest 25% on January 31, 2021, and thereafter quarterly over a three-year period.
F5 RSUs do not expire; they either vest or are canceled prior to vesting date.
F6 Each RSU converts into common stock on a one-for-one basis.
F7 These RSUs vest 25% on February 23, 2022, and thereafter monthly over a three-year period.

Remarks:

Exhibit 24 - Power of Attorney.